19.3 Evidence-Based Practice, Research Terminology, Quality Improvement & Patient Safety
Key Takeaways
Reliability is the consistency of a measure (test-retest, interrater, internal consistency with Cronbach's alpha of 0.70 or higher); validity is whether it measures what it claims to, and a measure can be reliable without being valid.
A p-value below 0.05 means results this extreme would be unlikely if the null hypothesis were true; statistical significance does not guarantee clinical significance.
A type I error is a false positive (rejecting a true null hypothesis, alpha); a type II error is a false negative (beta), and power (1 minus beta, usually 0.80) depends heavily on sample size.
Sensitivity and specificity are fixed properties of a test, while positive and negative predictive values change with disease prevalence; NNT is 1 divided by the absolute risk reduction.
SBAR, TeamSTEPPS 'CUS' words, closed-loop communication, and root cause analysis within a Just Culture are core interprofessional safety tools.
The Evidence-Based Practice Process
Evidence-based practice (EBP) combines the best research evidence, clinical expertise, and patient values and preferences.
- Ask a focused question in PICOT format: Population, Intervention, Comparison, Outcome, Time. Example: In postpartum women with preeclampsia (P), does home blood pressure monitoring (I), compared with office visits (C), increase completed blood pressure checks (O) within 10 days of discharge (T)?
- Acquire the evidence (databases, guidelines).
- Appraise it for validity, results, and applicability.
- Apply it, integrating patient preferences.
- Assess outcomes and disseminate the findings.
Hierarchy of Evidence (Strongest to Weakest for Intervention Questions)
- Systematic reviews and meta-analyses of randomized controlled trials (RCTs)
- Well-designed RCTs
- Controlled trials without randomization
- Cohort and case-control studies
- Systematic reviews of descriptive or qualitative studies
- Single descriptive or qualitative studies
- Expert opinion and committee reports
USPSTF grades: A (high certainty of substantial benefit), B (moderate to substantial benefit), C (small benefit, so individualize), D (no benefit or harm outweighs benefit, so recommend against), and I (insufficient evidence).
Study Designs
| Design | Description | Measure | Strengths and Limits |
|---|---|---|---|
| Randomized controlled trial | Participants randomly assigned to intervention or control, ideally blinded | Relative risk, absolute risk reduction | Best for causation; intention-to-treat analysis keeps randomization intact |
| Cohort (prospective or retrospective) | Groups defined by exposure, followed for outcomes | Relative risk, incidence | Good for common outcomes and multiple outcomes; prone to confounding |
| Case-control | Groups defined by outcome, looking back at exposures | Odds ratio | Efficient for rare diseases; recall bias |
| Cross-sectional | One point in time | Prevalence | Cannot establish temporal sequence |
| Qualitative (phenomenology, grounded theory, ethnography) | Explores lived experience and meaning | Themes | Rich understanding; not generalizable by design |
Research Terminology on the Blueprint
Reliability (Consistency)
- Test-retest: Similar results when repeated over time.
- Interrater: Agreement between observers (Cohen's kappa).
- Internal consistency: Items on a scale measure the same concept (Cronbach's alpha of 0.70 or higher is acceptable).
Validity (Accuracy)
- Measurement validity: Content validity (covers the domain), construct validity (measures the theoretical concept), and criterion validity (agrees with a gold standard, either concurrent or predictive).
- Internal validity: Confidence that the intervention, not bias or confounding, caused the outcome. Threats include selection bias, confounding, attrition, history, maturation, and testing effects.
- External validity: Generalizability to other populations and settings.
A measure can be reliable but not valid (consistently wrong), but it cannot be valid without being reliable.
Significance
- Statistical significance: A p-value below 0.05 means that, if there were truly no effect, results at least this extreme would occur less than 5% of the time. A 95% confidence interval that excludes 1 (for a ratio) or 0 (for a difference) is significant.
- Clinical significance: Whether the effect is large enough to matter to patients. A large study can make a trivial difference statistically significant.
- Type I error (alpha): Concluding there is an effect when there is none (false positive).
- Type II error (beta): Missing a real effect (false negative). Power = 1 − beta, typically set at 0.80, and rises with sample size and effect size.
Variables and Measurement Levels
- Independent variable (the intervention or exposure), dependent variable (the outcome), and confounders (related to both).
- Levels: nominal (categories, such as blood type), ordinal (ranked, such as pain mild/moderate/severe), interval (equal intervals, no true zero, such as temperature in °F), and ratio (true zero, such as weight).
Screening and Treatment Effect Math
| Term | Formula | Memory Aid |
|---|---|---|
| Sensitivity | True positives ÷ (true positives + false negatives) | SnNout: a negative result on a highly sensitive test rules out disease |
| Specificity | True negatives ÷ (true negatives + false positives) | SpPin: a positive result on a highly specific test rules in disease |
| Positive predictive value | True positives ÷ all positives | Rises with prevalence |
| Negative predictive value | True negatives ÷ all negatives | Falls as prevalence rises |
| Absolute risk reduction (ARR) | Control event rate − treatment event rate | |
| Relative risk reduction | ARR ÷ control event rate | |
| Number needed to treat (NNT) | 1 ÷ ARR |
Worked example: If preeclampsia occurs in 10% of controls and 6% of treated patients, ARR = 4%, relative risk reduction = 40%, and NNT = 1 ÷ 0.04 = 25. This is also why cfDNA has a lower positive predictive value in a young patient: the test's sensitivity and specificity are unchanged, but the condition is less prevalent.
Research Ethics and Utilization
- Belmont Report principles: Respect for persons (informed consent), beneficence, and justice.
- Institutional review boards protect participants; federal rules give additional protections to pregnant people, fetuses, prisoners, and children.
- Research utilization and implementation: Models such as the Iowa Model and Stetler Model guide translating evidence into practice, with pilot testing, staff education, and outcome evaluation.
Quality Improvement
- Donabedian framework: Structure (resources, staffing), process (what is done, such as the percentage of postpartum hypertensive patients with a blood pressure check within 10 days), and outcome (results, such as postpartum stroke rates), plus balancing measures that capture unintended effects.
- Model for Improvement: What are we trying to accomplish? How will we know a change is an improvement? What change can we make? Test changes with Plan-Do-Study-Act (PDSA) cycles, starting small and tracking data on run charts.
- QI vs. research: QI applies known evidence locally to improve care; research generates generalizable knowledge and requires IRB oversight. Projects that plan to publish generalizable findings may need IRB review.
Patient Safety
- Swiss cheese model: Harm occurs when holes in multiple defenses line up, so fix systems rather than blaming individuals.
- Just Culture: Console human error, coach at-risk behavior, and hold reckless behavior accountable.
- Root cause analysis: Required by The Joint Commission after sentinel events (for example, maternal death or severe maternal morbidity, wrong-site surgery, or a retained foreign object); it seeks system causes and an action plan.
- National Patient Safety Goals: Use two patient identifiers, reconcile medications, report critical results promptly, practice hand hygiene, and handle high-alert medications (insulin, magnesium sulfate, oxytocin, anticoagulants, opioids) with double checks.
- Disclosure: Communicate openly with patients after an adverse event, with an apology and an explanation of corrective steps (communication-and-resolution programs such as CANDOR).
Communication and Interprofessional Practice
- SBAR: Situation, Background, Assessment, Recommendation for concise handoffs and escalation.
- TeamSTEPPS tools: CUS ("I am Concerned, I am Uncomfortable, this is a Safety issue"), the two-challenge rule, call-outs, check-back (closed-loop communication), and structured handoffs (I-PASS).
- Chain of command: Escalate unresolved safety concerns up the clinical hierarchy.
- Simulation drills for obstetric hemorrhage, shoulder dystocia, and eclampsia improve team performance.
- Interprofessional Education Collaborative competencies: Values and ethics, roles and responsibilities, interprofessional communication, and teams and teamwork.
A WHNP is evaluating a new depression screening questionnaire. When the same patients complete it twice, 2 weeks apart, their scores are nearly identical. However, the questionnaire's scores correlate poorly with diagnoses made by structured psychiatric interviews. How should this tool be described?
Valid but not reliable
Both reliable and valid
Reliable but not valid
Neither reliable nor valid
In a randomized trial, postpartum hemorrhage occurred in 8% of patients receiving a standard regimen and 6% of patients receiving a new regimen. What is the number needed to treat with the new regimen to prevent one postpartum hemorrhage?
25
4
75
50
A labor nurse is concerned that a patient receiving oxytocin has a deteriorating fetal heart rate tracing, but the physician has not responded to two pages. Using TeamSTEPPS principles, what is the most appropriate action?
State the concern using CUS language and, if unresolved, escalate through the chain of command.
Document the concern in the chart and wait for the physician's next scheduled bedside check.
Increase the oxytocin rate to speed delivery before the physician arrives at the bedside.
Discuss the situation with the patient's family before contacting anyone else on the team.
Sections you finish are checked off in the contents.